BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 35643251)

  • 1. Association of Adjuvant Radiation Therapy With Long-Term Overall and Recurrence-Free Survival After Hepatectomy for Hepatocellular Carcinoma: A Multicenter Propensity-Matched Study.
    Gou XX; Shi HY; Li C; Chen ZL; Ouyang W; Sun LY; Diao YK; Wang MD; Yao LQ; Gu LH; Pawlik TM; Lau WY; Shen F; Xue J; Yang T
    Int J Radiat Oncol Biol Phys; 2022 Oct; 114(2):238-249. PubMed ID: 35643251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical Margin Affects the Long-Term Prognosis of Patients With Hepatocellular Carcinoma Undergoing Radical Hepatectomy Followed by Adjuvant TACE.
    Bai S; Yang P; Liu J; Xue H; Xia Y; Liu F; Yang Z; Zhang L; Wu Y; Shen F; Wang K
    Oncologist; 2023 Aug; 28(8):e633-e644. PubMed ID: 37029989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative transcatheter arterial chemoembolization for surgical resection of huge hepatocellular carcinoma (≥ 10 cm): a multicenter propensity matching analysis.
    Li C; Wang MD; Lu L; Wu H; Yu JJ; Zhang WG; Pawlik TM; Zhang YM; Zhou YH; Gu WM; Wang H; Chen TH; Han J; Xing H; Li ZL; Lau WY; Wu MC; Shen F; Yang T
    Hepatol Int; 2019 Nov; 13(6):736-747. PubMed ID: 31486964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant immunotherapy improves recurrence-free and overall survival following surgical resection for intermediate/advanced hepatocellular carcinoma
    Xu X; Wang MD; Xu JH; Fan ZQ; Diao YK; Chen Z; Jia HD; Liu FB; Zeng YY; Wang XM; Wu H; Qiu W; Li C; Pawlik TM; Lau WY; Shen F; Lv GY; Yang T
    Front Immunol; 2023; 14():1322233. PubMed ID: 38268916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Surgical Margin Width on Patterns of Recurrence among Patients Undergoing R0 Hepatectomy for T1 Hepatocellular Carcinoma: An International Multi-Institutional Analysis.
    Tsilimigras DI; Sahara K; Moris D; Hyer JM; Paredes AZ; Bagante F; Merath K; Farooq AS; Ratti F; Marques HP; Soubrane O; Azoulay D; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Guglielmi A; Hugh T; Aldrighetti L; Endo I; Pawlik TM
    J Gastrointest Surg; 2020 Jul; 24(7):1552-1560. PubMed ID: 31243714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of primary tumor location with long-term oncological prognosis following hepatectomy for hepatocellular carcinoma:A multicenter propensity score matching analysis.
    Tang SC; Lin KY; Huang TF; Zhang KL; Kong J; He XL; Luo C; Chen QJ; Guo PF; Zhou WP; Zeng YY
    Eur J Surg Oncol; 2023 Jul; 49(7):1234-1241. PubMed ID: 36774217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant anti-PD-1 antibody for hepatocellular carcinoma with high recurrence risks after hepatectomy.
    Chen W; Hu S; Liu Z; Sun Y; Wu J; Shen S; Peng Z
    Hepatol Int; 2023 Apr; 17(2):406-416. PubMed ID: 36645648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anatomical versus non-anatomical resection for solitary hepatocellular carcinoma without macroscopic vascular invasion: A propensity score matching analysis.
    Zhao H; Chen C; Gu S; Yan X; Jia W; Mao L; Qiu Y
    J Gastroenterol Hepatol; 2017 Apr; 32(4):870-878. PubMed ID: 27671209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter propensity score analysis of significance of hepatic resection type for early-stage hepatocellular carcinoma.
    Tang SC; Zhang KL; Lin KY; Tang YD; Fu J; Zhou WP; Zhang JX; Kong J; He XL; Sun ZH; Luo C; Liu HZ; Lai YP; Zeng YY
    Hepatol Int; 2024 Apr; 18(2):623-635. PubMed ID: 37880566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival benefit of radiotherapy following narrow-margin hepatectomy in patients with hepatocellular carcinoma: A propensity score-matched analysis based on phase II study.
    Long L; Chen B; Wang H; Zhao Y; Wu F; Wang L; Rong W; Wu J; Li Y; Wang W
    Radiother Oncol; 2023 Mar; 180():109462. PubMed ID: 36634853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of adjuvant TACE on the prognosis of patients with HCC after hepatectomy: a multicenter propensity score matching from China.
    Wu Z; Cui L; Qian J; Luo L; Tu S; Cheng F; Yuan L; Zhang W; Lin W; Tang H; Li X; Li H; Zhang Y; Zhu J; Li Y; Xiong Y; Hu Z; Peng P; He Y; Liu L; He K; Shen W
    BMC Cancer; 2023 Apr; 23(1):325. PubMed ID: 37029339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant radiotherapy provided survival benefit compared to adjuvant radiotherapy for hepatocellular carcinoma.
    Lin H; Li X; Liu Y; Hu Y
    ANZ J Surg; 2018 Oct; 88(10):E718-E724. PubMed ID: 29399938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anatomic resection versus radiofrequency ablation with an ablative margin ≥ 1.0 cm for solitary small hepatocellular carcinoma measuring ≤ 3 cm: Comparison of long-term outcomes using propensity score matching analysis.
    Zhang C; Gao R; Guo S; Ning C; Li A; Wang X; Li S; Ding J; Kong X; Wang Q; Xu Y; Li J; Gao J; Wang S; Kong J; Ke S; Sun W
    Eur J Radiol; 2022 Oct; 155():110498. PubMed ID: 36049409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatectomy for Solitary Hepatocellular Carcinoma: Resection Margin Width Does Not Predict Survival.
    Michelakos T; Kontos F; Sekigami Y; Qadan M; Cai L; Catalano O; Deshpande V; Patel MS; Yamada T; Elias N; Dageforde LA; Kimura S; Kawai T; Tanabe KK; Markmann JF; Yeh H; Ferrone CR
    J Gastrointest Surg; 2021 Jul; 25(7):1727-1735. PubMed ID: 32779082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiofrequency ablation versus repeat resection for recurrent hepatocellular carcinoma (≤ 5 cm) after initial curative resection.
    Feng Y; Wu H; Huang DQ; Xu C; Zheng H; Maeda M; Zhao X; Wang L; Xiao F; Lv H; Liu T; Qi J; Li J; Zhong N; Wang C; Feng H; Liang B; Ren W; Qin C; Nguyen MH; Zhu Q
    Eur Radiol; 2020 Nov; 30(11):6357-6368. PubMed ID: 32529568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perioperative and long-term survival outcomes of laparoscopic versus laparotomic hepatectomy for BCLC stages 0-A hepatocellular carcinoma patients associated with or without microvascular invasion: a multicenter, propensity score matching analysis.
    Yang SY; Yan ML; Duan YF; Feng JK; Ye JZ; Xiang YJ; Liu ZH; Guo L; Xue J; Cheng SQ; Guo WX
    Hepatol Int; 2022 Aug; 16(4):892-905. PubMed ID: 35704267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Survival Analysis of Stereotactic Ablative Radiotherapy Versus Liver Resection for Small Hepatocellular Carcinoma.
    Su TS; Liang P; Liang J; Lu HZ; Jiang HY; Cheng T; Huang Y; Tang Y; Deng X
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):639-646. PubMed ID: 28581406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase 2 Study of Adjuvant Radiotherapy Following Narrow-Margin Hepatectomy in Patients With HCC.
    Chen B; Wu JX; Cheng SH; Wang LM; Rong WQ; Wu F; Wang SL; Jin J; Liu YP; Song YW; Ren H; Fang H; Tang Y; Li N; Li YX; Wang WH
    Hepatology; 2021 Nov; 74(5):2595-2604. PubMed ID: 34097307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the effect of the Aquamantys
    Sui MH; Wang HG; Chen MY; Wan T; Hu BY; Pan YW; Li H; Cai HY; Cui C; Lu SC
    Clin Transl Oncol; 2019 Dec; 21(12):1634-1643. PubMed ID: 30911882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeat hepatectomy for patients with early and late recurrence of hepatocellular carcinoma: A multicenter propensity score matching analysis.
    Xing H; Sun LY; Yan WT; Quan B; Liang L; Li C; Zhou YH; Wang H; Zhong JH; Gu WM; Chen TH; Wang MD; Wu H; Pawlik TM; Lau WY; Wu MC; Shen F; Yang T
    Surgery; 2021 Apr; 169(4):911-920. PubMed ID: 31879090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.